ARCHIVES

FDA Approves Silicone Gel Breast Implants, Requires 10 Years Of Patient Follow-Up

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | November 24, 2006

Download PDF Visit The Full Archive

Related Articles

Nine Saturation Program Planning Winners Names NCI May Reissue RFP Later This Year

May 23, 1975

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

December 10, 2004

Advisors Urge NCI To Support Basic Chemoprevention.

January 7, 2000

Lymphoseek Label Updated To Include Head and Neck SCC

June 27, 2014

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

In Brief: Ahoy! It’s “Admiral Rick”

April 2, 1999